The only misclassified tumour using the BRCA1 classifier had BRCA1 promoter hypermethylation and reduced BRCA1 expression, suggesting tumours without a pathogenic variant may display a “BRCA-like” phenotype. This evidence concerns the gene BRCA1 and neoplasm.